{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:35:57Z","timestamp":1790548557329,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001081","name":"Hunter Medical Research Institute (HMRI)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bpobgyn.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T18:39:25Z","timestamp":1523644765000},"page":"48-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Preventing preterm birth: New approaches to labour therapeutics using Nanoparticles"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3064-6358","authenticated-orcid":false,"given":"Jonathan W.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2018.03.005_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib2","doi-asserted-by":"crossref","first-page":"e6226","DOI":"10.1136\/bmj.e6226","article-title":"Tocolytic therapy for preterm delivery: systematic review and network meta-analysis","volume":"345","author":"Haas","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles:applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood","volume":"371","author":"Saigal","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib5","first-page":"1020","article-title":"The management of preterm labor","volume":"100","author":"Goldenberg","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1515\/JPM.2006.073","article-title":"Guidelines for the management of spontaneous preterm labor","volume":"34","author":"Di Renzo","year":"2006","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/jcp.2008.055244","article-title":"The placenta in preterm birth","volume":"61","author":"Faye-Petersen","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib8","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/1471-0528.13515","article-title":"Economic costs associated with moderate and late preterm birth: a prospective population-based study","volume":"122","author":"Khan","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/IJWH.S44048","article-title":"Short-term tocolytics for preterm delivery - current perspectives","volume":"6","author":"Haas","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/14767058.2014.918095","article-title":"Tocolysis for acute preterm labor: does anything work","volume":"28","author":"Haram","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/14656566.2014.889684","article-title":"Preterm labor: current pharmacotherapy options for tocolysis","volume":"15","author":"van Vliet","year":"2014","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug transfer and metabolism by the human placenta","volume":"43","author":"Syme","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib15","series-title":"Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. Natural polymer drug delivery systems","author":"Bhatia","year":"2016"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/138920111795471010","article-title":"Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure","volume":"12","author":"Menezes","year":"2011","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fphar.2013.00143","article-title":"The use of lipid-based nanocarriers for targeted pain therapies","volume":"4","author":"Hua","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-3155-2-3","article-title":"Applications of nanoparticles in biology and medicine","volume":"2","author":"Salata","year":"2004","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.biotechadv.2013.08.003","article-title":"Highlights of recent developments and trends in cancer nanotechnology research\u2013view from NCI alliance for nanotechnology in Cancer","volume":"32","author":"Hull","year":"2014","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib22","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.6004\/jnccn.2014.0175","article-title":"Nanotechnologies in cancer treatment and diagnosis","volume":"12","author":"Morris","year":"2014","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0002-9378(90)90427-9","article-title":"Placental transfer of indomethacin in the human pregnancy","volume":"162","author":"Moise","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9378(94)70392-2","article-title":"Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate","volume":"170","author":"Major","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib25","first-page":"921","article-title":"Indomethacin tocolysis and intraventricular hemorrhage","volume":"97","author":"Suarez","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0002-9378(11)90763-7","article-title":"Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use","volume":"168","author":"Moise","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mob.2002.127464","article-title":"The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate","volume":"187","author":"Suarez","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9378(97)70184-4","article-title":"The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age","volume":"177","author":"Vermillion","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.reprotox.2008.06.008","article-title":"Kinetics of gold nanoparticles in the human placenta","volume":"26","author":"Myllynen","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1289\/ehp.0901200","article-title":"Barrier capacity of human placenta for nanosized materials","volume":"118","author":"Wick","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1042\/bst0080559","article-title":"The fate in\u00a0vivo of liposomally entrapped drugs in pregnant rats","volume":"8","author":"Tuzel","year":"1980","journal-title":"Biochem Soc Trans"},{"issue":"546","key":"10.1016\/j.bpobgyn.2018.03.005_bib32","first-page":"e5","article-title":"Size of the nanovectors determines the transplacental passage in pregnancy: study in rats","volume":"204","author":"Refuerzo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1743-8977-10-21","article-title":"Biodistribution and toxicity of pegylated single wall carbon nanotubes in pregnant mice","volume":"10","author":"Campagnolo","year":"2013","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.lfs.2012.08.021","article-title":"Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model","volume":"91","author":"Kaga","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/smll.200902049","article-title":"Transfer of quantum dots from pregnant mice to pups across the placental barrier","volume":"6","author":"Chu","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib36","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/smll.200800922","article-title":"Biodistribution of 1.4- and 18-nm gold particles in rats","volume":"4","author":"Semmler-Behnke","year":"2008","journal-title":"Small"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib37","first-page":"111","article-title":"Potential utility of liposome bupivacaine in orthopedic surgery","volume":"44","author":"Lonner","year":"2015","journal-title":"Am J Orthop (Belle Mead NJ)"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome((R))): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib39","doi-asserted-by":"crossref","first-page":"e0133569","DOI":"10.1371\/journal.pone.0133569","article-title":"Efficacy and cardiotoxicity of liposomal doxorubicin-based chemotherapy in advanced breast cancer: a meta-analysis of ten randomized controlled trials","volume":"10","author":"Xing","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0002-9378(16)32341-9","article-title":"Biochemistry and pharmacology of the myometrium and labor: regulation at the cellular and molecular levels","volume":"142","author":"Huszar","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib41","series-title":"A\u00a0targeted drug delivery system for the uterus. Reproductive Sciences: Society of Reproductive Investigation","first-page":"57A","author":"Paul","year":"2015"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/mi.6.2.7","article-title":"Advanced drug delivery systems that target the vascular endothelium","volume":"6","author":"Ding","year":"2006","journal-title":"Mol Interv"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fphar.2013.00127","article-title":"Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies","volume":"4","author":"Hua","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1359-6446(03)02699-0","article-title":"Targeted drug delivery systems for the intracellular delivery of macromolecular drugs","volume":"8","author":"Koning","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/17425247.2.3.465","article-title":"Liposomes in the treatment of inflammatory disorders","volume":"2","author":"Metselaar","year":"2005","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib46","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1038\/ncomms5108","article-title":"Diminished hERG K+ channel activity facilitates strong human labour contractions but is dysregulated in obese women","volume":"5","author":"Parkington","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0091-679X(08)60468-9","article-title":"Lipid vesicles as carriers for introducing biologically active materials into cells","volume":"14","author":"Poste","year":"1976","journal-title":"Meth Cell Biol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib48","first-page":"123","article-title":"Fate and behavior of liposomes in\u00a0vivo: a review of controlling factors","volume":"3","author":"Senior","year":"1987","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib49","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1210\/endo.136.9.7649111","article-title":"Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization","volume":"136","author":"Adan","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.08.027","article-title":"Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor","volume":"216","author":"Paul","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib51","doi-asserted-by":"crossref","first-page":"350546","DOI":"10.1155\/2011\/350546","article-title":"The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents","volume":"2011","author":"Vrachnis","year":"2011","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib52","first-page":"Cd004452","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","author":"Flenady","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bcp.12646","article-title":"Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study","volume":"80","author":"Thornton","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib54","doi-asserted-by":"crossref","first-page":"34710","DOI":"10.1038\/srep34710","article-title":"Uterus-targeted liposomes for preterm labor management: studies in pregnant mice","volume":"6","author":"Refuerzo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib55","article-title":"Liposomes: a nanoscale drug carrying system to prevent indomethacin passage to the fetus in a pregnant mouse model","volume":"212","author":"Refuerzo","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib56","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1073\/pnas.73.5.1603","article-title":"Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells","volume":"73","author":"Poste","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib57","first-page":"349","article-title":"Endometriosis still a challenge","volume":"7","author":"Mehedintu","year":"2014","journal-title":"J\u00a0Med life"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2217\/whe.15.50","article-title":"In\u00a0vitro fertilization for endometriosis-associated infertility","volume":"11","author":"Polat","year":"2015","journal-title":"Women's health (London, England)"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib59","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/humrep\/der195","article-title":"The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model","volume":"26","author":"Schwager","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib60","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/1933719115578930","article-title":"The targeted delivery of interleukin 4 inhibits development of endometriotic lesions in a mouse model","volume":"22","author":"Quattrone","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib61","series-title":"Antigens associated with endometriosis","author":"Schwager","year":"2009"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib62","doi-asserted-by":"crossref","first-page":"e1600349","DOI":"10.1126\/sciadv.1600349","article-title":"Tumor-homing peptides as tools for targeted delivery of payloads to the placenta","volume":"2","author":"King","year":"2016","journal-title":"Sci adv"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2018.03.005_bib63","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1540\/jsmr.53.73","article-title":"The expression of genes involved in myometrial contractility changes during ex situ culture of pregnant human uterine smooth muscle tissue","volume":"53","author":"Ilicic","year":"2017","journal-title":"J\u00a0Smooth Muscle Res"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib65","doi-asserted-by":"crossref","first-page":"4589214","DOI":"10.1155\/2017\/4589214","article-title":"Modulation of progesterone receptor isoform expression in pregnant human myometrium","volume":"2017","author":"Ilicic","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.bpobgyn.2018.03.005_bib66","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2217\/nnm.15.48","article-title":"Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy","volume":"10","author":"Keelan","year":"2015","journal-title":"Nanomedicine (Lond)"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:28:05Z","timestamp":1751563685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693418300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":66,"alternative-id":["S1521693418300713"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.03.005","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing preterm birth: New approaches to labour therapeutics using Nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}